Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.

This article reviews the data documenting the efficacy and safety of three types of biologics. Semin Cutan Med Surg 35(supp4):S74-S77. PMID: 29850661 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29850661?dopt=Abstract

Source: Seminars in Cutaneous Medicine and Surgery - June 3, 2018 Category: Dermatology Tags: Semin Cutan Med Surg Source Type: research

More News: Dermatology | Psoriasis